7:30-8:15 |
Welcome to the 30th Anniversary OCRA-DG Annual Conference
Registration/Pick up Badge & Light Breakfast |
8:15-8:30 |
Ceremony and Welcome Address
Welcome note by the President of OCRA-DG and Conference Chair |
8:30-9:00 |
Opening Plenary: Landscape of Imports & Exports of FDA-Regulated Products |
9:00-9:15 |
Transition Break |
TRACKS |
Track A
(Pharma/Biologics) |
Track B
(Devices/Diagnostics/Combination Product)
|
9:15-10:15 |
Postmarketing Surveillance Expectations and Compliance |
The Role of Real World Evidence in Supporting Medical Device Regulatory Submissions (Global) |
10:15-10:30 |
Networking Break with refreshments |
10:30-11:30 |
Gene therapy |
European In Vitro Diagnostic Regulation (EU IVDR) |
11:30-12:30 |
Lunch |
12:30-1:30 |
Regulatory Compliance Landscape and GMP Surveillance |
Computational Modeling and Simulation in Medical Device Submissions |
1:30-1:45 |
Networking Break with refreshments |
1:45-2:45 |
FDA Current Regulations of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) |
Artificial Intelligence in Medical Devices |
2:45-3:00 |
Networking Break with refreshments |
3:00-4:00 |
Quality Management Maturity and Essential Tools to be Audit Ready |
Navigate the Recent Updates and Challenges in Combination Products Regulatory Landscape |
4:00-4:15 |
Transition Break |
4:15-4:50 |
Closing Plenary: Looking to the Horizon – Innovations in regulatory profession
– Reorganization of ORA and Centers taking direct lead in Compliance
– How FDA reorganization impacts industry
– Global inspection readiness using inspection software with AI |
4:50-5:00 |
Closing Remarks
OCRA-DG President and Chair |
5:30-closing |
Social Reception – Complimentary Food and Beverages (Open Bar) |